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areas included eyelid (1), nasal dorsum (7), pre auricular 
region (1), forehead (2) and cheek (1). The planning method 
was identical to all lesions, although two different 
immobilization techniques were applied, depending on the 
size and location of the lesion. The first technique was 
applied in facial lesions (11) and large lesions of the thorax 
(4): first the lesion was delineated with a radiopaque marker, 
followed by the immobilization of the patient with a 
thermoplastic mask, then one bolus plaque of 2 mm thickness 
was applied above the mask and the plastic catheters were 
placed and immobilized with two bolus plaques. The second 
technique was applied in small central lesions of the thorax 
(2) and in the eyelid: after the delineation of the lesion with 
a radiopaque marker, bolus plaques were placed directly 
above and the plastic catheters were placed and immobilized 
with two bolus plaques. In these cases, the limits of the mold 
were tattooed in the patient for reproducibility between 
fractions. The distance between catheters was always 10 
mm. A planning CT with 1,25 (facial) and 2,5 mm (thoracic) 
slice thickness was acquired. The treatment planning was 
developed by the treatment planning system (TPS) Oncentra 
MasterPlan v4.1 taking into account the prescription points, 
dose to the skin and doses to the organs at risk (OAR). The 
dose was prescribed to points at 0 (eyelid) and 3 mm depth. 
All patients were treated by a microSelectron v3 (Elekta) that 
used a 192Ir source. Eye protectors were used when necessary 
and the standard fractionation was 40 Gy in 10 fractions 
twice weekly. Dosimetric plans were analyzed for the 
following parameters: dose to the OAR, dose to the skin and 
dose to the prescribing points. The QA procedure was done 
using mosfets and gafchromic films.  
Results: The doses to the OAR were converted to Biologically 
Effective Dose (BED) and were always under their maximum 
tolerance dose. The dose verification results were accepted 
within a range of 10 % deviation of the planned dose to the 
prescribing points and to the skin. 
Conclusions: This technique showed to be a viable option to 
facial and thoracic skin lesions. Due to the steep dose 
gradient of the 192Ir sources used in brachytherapy, adjacent 
healthy tissue and deep structures are spared to irradiation. 
Furthermore, as masks and applicators are flexible, it is 
possible to treat lesions in irregular or curved surfaces 
assuring catheter fixation and treatment reproducibility 
between fractions. 
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Purpose/Objective: In the quality control program of the 
system used in prostate permanent implants (PPI) one of the 
tests should be the verification of mean value of seed 
strength of the whole lot of seeds to use in PPI. In this study 
we have compared the activity of two samples of seeds from 
the same cartridge. We measured mean value of air kerma 
strength (SK) of one sample with an ionization chamber, as 
the other sample was measured, in internal units, with the 
diode system integrated in the afterloader equipment. The 
lineal relationship found between both measures could be 
used to predict SK of the cartridge of seeds. 
Materials and Methods: Measured seeds, selectSeed I125, are 
contained in sterile cartridges. The cartridges included in the 
study were 19, used along 2013 and 2014. In all cases the 
cartridge calibration certificate determines a SK value of 
0.610 cGy/h cm2 with an uncertainty of ± 4%. Prostate seed 
implants were made more than seven days after the 
calibration certificate date. Nucletron application Software 
seedSelectron v1.26b controls the construction of each seed 
configuration. The source strength measured of each seed 
that is taken out of the cartridge by Nucletron afterloader, 
seedLoader, is registered in a log file.This measurement is 
made by diodes included in the afterloader. For each case in 
this study, the average value of all seeds used in the implant 
is calculated from the diode measurement (DL). Following the 
implant, SK of a seed sample from the cartridge is measured 
with well ionization chamber SourceCheck of PTW (whichever 
was smaller, 10% of the initial number of seeds in the 
cartridge or the seeds remaining therein). A decay factor is 
applied to this measure to obtain the corresponding value 
upon completion of the implant, i.e. when measured by the 
afterloader equipment. 
Results: Figure 1 shows the scatter plot with DL as an 
independent variable and the SK measurement of the 
chamber as a dependent variable (DV). The regression line 
(corrected R2 = 0.747) and the lines of CI 95% for individuals 
are included. Linear regression satisfies the assumptions of 
independence (Durbin-Watson = 2.063), homoscedasticity and 
normality of residuals (p=0.737 Shapiro-Wilk test). For 
residuals, standard deviation (SD) was 0.003 cGy/h cm2, i.e. 
0.5% of the mean value of the DV (0.552 cGy/h cm2). The 
mean value of coefficient of variation (CV) in measures with 
afterloader was 3.4% with SD 0.9% whereas with ionization 
chamber the mean value of CV was 1.9% with SD 0.7%. 
 
 
Conclusions: Measurements of diode array and use of the 
regression allow calculation of SK of the seed cartridge and 
the comparison with calibration certificate. Limit values of 
disagreement with manufacturer should be increased by 
±1.1%. Due to the higher value of CV, the afterloader has less 
accuracy than ionization chamber. Afterloader can not be 
used to compare source strength of individual seeds with the 
average value for cartridge. 
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Purpose/Objective: Planning and executing a HDR (High Dose 
Rate) intracavitary brachytherapy treatment for cervical 
carcinoma can involve several patient bed transfers. In the 
current study, patients have to be moved twice, and undergo 
four bed transfers which can imply a cylinder dislocation 
from its initial position immediately after the cylinder 
implant. This study aims to quantify the cylinder 
displacement due to patient manipulation after the initial 
implant position, at CT scan acquisition moment and during 
treatment. 
Materials and Methods: Nineteen patients were included in 
this study. The patients underwent three fractions of 
intracavitary brachytherapy using vaginal cylinders with 
diameters ranging from 20 mm to 40 mm. In the first session, 
after cylinder positioning, two orthogonal x-rays (antero-
posterior and lateral) are acquired. Then the patient is 
transported to the CT room for treatment planning image 
acquisition. At last, the patient is carried to the treatment 
room, where two additional x-ray images, in the same 
conditions as after the implant, are also acquired. The 
treatment dose is prescribed at a point located 0.5 cm from 
the cylinder wall and the treated extension is 3 cm. The 
deviations of the applicator caused by the movement of the 
patient were assessed with regard to distances and angles 
between fixed points on the cylinder and the bony structure 
of the patient. The evaluated parameters were: A) the 
distance between the lower ring of the cylinder and the 
superior limit of the pubic symphysis (point 'x' in Figure 1A); 
B) the angle formed by two straight lines that start at the 
intersection of the central axis of the cylinder with the 
superior limit of the pubic symphysis (angle 'α' in Figure 1B) 
extending to the upper ring (point 'a' in Figure 1B) and the 
other to the supero-lateral limit of obturator foramen (point 
'b' in Figure 1B); and C) distances between the treatment 
couch and the central axis on the upper and lower rings 
(points 'y1' and 'y2' in Figure 1C). 
 
 
Results: The observed geometrical deviations of the vaginal 
cylinders from its initial position varied as follows: 'x' varied 
from 0 cm to 1.4 cm with an average of 0.39 cm (SD = 0.36 
cm); 'α' from 0.06º to 6.53º, with and average of 1.93º (SD = 
1.61 cm). Measurements of y1 and y2 could not be evaluated 
due to large geometric uncertainty. 
Conclusions: Although the maximum deviation of 'x' exceeds 
the prescription depth, the dose delivered to the vaginal 
mucosa is equal, since this tissue is elastic and follows the 
cylinder movement. Nevertheless, undetermined 
consequences on the dose distribution in organs at risk might 
arise. The evaluation of the dose uncertainty at healthy 
tissues will be assessed in a future development of this work.  
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Purpose/Objective: In the multidisciplinary therapy era for 
high risk prostate cancer, external beam radiation therapy is 
often combined with brachytherapy boost. We have 
investigated the impact of implanted seeds on dose 
distributions for prostate VMAT by way of Monte Carlo 
calculation and film measurement. 
Materials and Methods: Iodine-125 seeds, OncoSeed (Oncura, 
USA), were implanted into a prostate training phantom for 
brachytherapy, Model 053 (CIRS, USA), and the phantom was 
positioned in water with an acrylic enclosure. VMAT plans for 
the prostate phantom with and without the seeds were 
created by a Monte Carlo based TPS, Monaco (Elekta, 
Sweden) and the dose distributions were calculated. Another 
Monte Carlo code, EGSnrc, was also employed to compare 
calculated dose distributions. Radiochromic films were also 
used to measure dose distributions inside the phantom. 
Results: It was observed that the calculated dose differences 
with and without the seeds using either Monaco or EGSnrc 
were negligibly small. It was further confirmed that the 
measured dose differences with and without the seeds were 
also insignificant. These results suggested that the VMAT 
beams from multiple directions may compensate any small 
dose perturbation by way of spatial averaging. 
Conclusions: We observed that the impact of brachytherapy 
seeds on prostate VMAT dose delivery may be insignificant, 
thereby encouraging a use of seeds for brachytherapy 
followed by prostate VMAT.  
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Purpose/Objective: To look retrospectively at the effects in 
needle number and post-implant doses of increasing the 
activity of the seeds used in prostate implants from 
0.356mCi-0.369mCi to 0.536mCi-0.555mCi. CT scans after 
implants are used to find prostate, rectum and bladder doses 
indicative of dosimetric coverage and dose to organs at risk. 
The aim of this work is to assess whether the use of higher 
activity seeds reduces needle related trauma can be reduced 
whilst maintaining adequate coverage as well as maintaining 
adequate OAR sparing.  
Materials and Methods: Patients with prostate volumes over 
40cc with associated post-implant data (6 weeks post 
treatment) were included in the study. A mean value and 
range is found for the needle number and post implant 
dosimetric parameters. All patients were planned with the 
same dose constraints with regards to prostate coverage and 
OAR sparing.  
